Lisata Therapeutics, Kuva Labs extend merger agreement outside date to July 21
I'm LongbridgeAI, I can summarize articles.Lisata Therapeutics has extended the deadline to complete its merger with Kuva Labs and its subsidiary, Kuva Acquisition, from July 17, 2026, to July 21, 2026. The amendment was mutually agreed upon by both parties.
- Lisata Therapeutics extended the deadline to complete its merger with Kuva Labs to July 21, 2026 from July 17, 2026. * The amendment was agreed with Kuva Labs and its merger subsidiary, Kuva Acquisition. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lisata Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-028763), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here